deep caries partial pulpotomy irreversible pulpitis ProRoot MTA® Biodentine 6-
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patient inclusion criteria 1. American Society of Anesthesiologists I or II (ASA I or II) pediatric patients aged between 6-18 years old. 2. Cooperative patients 3. The legal guardians allow the child to participate and the child agrees to participate in the study and sign the informed consent and assent forms, respectively Tooth clinical criteria A. Tooth clinical inclusion criteria Pre-operative clinical inclusion criteria 1. Tooth with deep caries diagnosed with irreversible pulpitis 2. Tooth that has a positive response to sensibility test (cold test) 3. Tooth that is restorable with resin composite or stainless steel crown 4. Absence of clinical swelling, pus exudate/ fistula of soft and periodontal tissues 5. Absence of abnormal tooth mobility Intra-operative clinical inclusion criteria 1. After complete caries removal, exposure of pulpal tissue occurs. 2. Size of pulp exposure is larger than 1 mm. but not larger than 5 mm. in diameter, as measured by a sterilized preformed wire. 3. Pulp tissue appears vital judging from color and amount of bleeding. 4. Bleeding from pulp exposure site can be controlled within 10 minutes. Radiographic criteria A. Radiographic inclusion criteria Bitewing radiograph 1. The extension of the dental caries radiolucency penetrates into three fourth or more of the entire dentin thickness. Paralleled periapical radiograph 1. No prominent radiolucency at the furcation or periapical regions 2. Absence of internal and/or pathologic external root resorption 3. Absence of calcification/ or pulp canal obliteration Note: The presence of early periapical lesions, such as widened periodontal ligament (PDL) space or condensing osteitis was not considered an exclusion criteria for this study.
Exclusion criteria
Exclusion criteria: Patient exclusion criteria Pediatric patients who have systemic disease or contraindicated for vital pulp therapy such as congenital heart disease, bleeding disorder, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| clinical and radiographic success every 6 month clinical and radiographic examination | — |
Secondary
| Measure | Time frame |
|---|---|
| discoloration 6 months photograph | — |
Countries
Thailand
Contacts
Faculty of Dentistry Chiang Mai University